Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00495222 · ClinicalTrials.gov registry record · NA

Endoscopic Suturing System for Tissue Apposition

A NA study of Obesity, sponsored by Ethicon Endo-Surgery.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT00495222 is a NA study of Obesity that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 9 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00495222, a NA study of Obesity, has completed, sponsored by Ethicon Endo-Surgery.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The objective of this feasibility trial is to evaluate the Ethicon Endo-Surgery Endoscopic Suturing System (ESS) for tissue apposition and reduction of the size of a dilated GJ anastomosis in subjects who are regaining weight after successful weight loss following gastric bypass. Post-procedure weight will be followed to assess whether weight loss is resumed. The ESS is an FDA-cleared (510(k)) sterile, single-use, disposable suturing system indicated for endoscopic placement of suture(s) and approximation of soft tissues. It is designed to facilitate endoscopic gastrointestinal procedures.

Conditions Studied

Interventions

  • PROCEDURE Tissue plication
  • DEVICE Endoscopic Suturing System
  • DEVICE Tissue Plication

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2007-02
Est. Completion 2008-06
Phase NA

Sponsor

Ethicon Endo-Surgery

39 total trials

What the Registry Record Tells You About NCT00495222

The ClinicalTrials.gov registry entry for NCT00495222 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Tissue plication is the first listed.

NCT00495222 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00495222 about?

NCT00495222 is a clinical study titled "Endoscopic Suturing System for Tissue Apposition". The objective of this feasibility trial is to evaluate the Ethicon Endo-Surgery Endoscopic Suturing System (ESS) for tissue apposition and reduction of the size of a dilated GJ anastomosis in subjects who are regaining weight after successful weight loss following gastric bypass. Post-procedure weig...

What is the current status of trial NCT00495222?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2007-02. Estimated completion is 2008-06.

What conditions does trial NCT00495222 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00495222?

The interventions under investigation include: Tissue plication (PROCEDURE), Endoscopic Suturing System (DEVICE), Tissue Plication (DEVICE).

Who is sponsoring clinical trial NCT00495222?

This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00495222 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.